Profile data is unavailable for this security.
About the company
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
- Revenue in USD (TTM)2.80m
- Net income in USD73.00k
- Incorporated2010
- Employees1.00
- LocationTherapeuticsMD Inc951 Yamato Road, Suite 220BOCA RATON 33431United StatesUSA
- Phone+1 (561) 961-1900
- Websitehttps://www.therapeuticsmd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp | 522.00k | -10.79m | 16.97m | 7.00 | -- | 3.08 | -- | 32.50 | -0.5743 | -0.5743 | 0.0272 | 0.221 | 0.0659 | -- | 2.97 | 74,571.43 | -136.35 | -102.60 | -145.39 | -105.78 | 100.00 | 87.95 | -2,069.41 | -1,579.38 | -- | -285.30 | 0.00 | -- | 52.05 | 17.53 | -105.37 | -- | 48.50 | -- |
| Natural Alternatives International Inc | 134.44m | -11.88m | 20.51m | 293.00 | -- | 0.2971 | -- | 0.1525 | -1.99 | -1.99 | 22.52 | 11.17 | 0.845 | 4.35 | 7.36 | 458,839.60 | -7.47 | 0.4593 | -9.15 | 0.5479 | 8.50 | 12.75 | -8.84 | 0.4296 | 1.01 | -2.56 | 0.1408 | 0.00 | 14.12 | 1.78 | -88.10 | -- | -4.46 | -- |
| Global Pharmatech Inc. | 3.18m | -2.24m | 20.76m | 217.00 | -- | 0.1459 | -- | 6.53 | -0.0964 | -0.0964 | 0.1367 | 0.3428 | 0.2292 | 1.59 | 3.57 | 14,649.77 | -16.44 | -- | -22.55 | -- | 46.21 | -- | -71.75 | -- | 1.62 | -9.87 | 0.2223 | -- | 32.43 | -- | -142.03 | -- | -- | -- |
| Nutraproducts Inc | 0.00 | -821.94k | 20.92m | 0.00 | -- | 3.50 | -- | -- | -1.31 | -1.31 | 0.00 | 0.2973 | 0.00 | -- | -- | -- | -513.70 | -1,177.23 | -740.45 | -- | -- | -- | -- | -- | -- | -385.17 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Dare Bioscience Inc | 27.69k | -17.46m | 24.15m | 21.00 | -- | 8.24 | -- | 872.11 | -1.92 | -1.92 | 0.0029 | 0.2052 | 0.0011 | -- | 0.0624 | 1,318.57 | -71.56 | -91.64 | -241.96 | -243.93 | 127.70 | -- | -63,069.55 | -1,024.05 | -- | -156.39 | 0.7177 | -- | -99.65 | -- | 86.56 | -- | -- | -- |
| Aytu Biopharma Inc | 62.64m | -24.56m | 24.79m | 82.00 | -- | 1.75 | -- | 0.3958 | -3.40 | -3.39 | 5.63 | 1.32 | 0.5259 | 2.10 | 2.22 | 763,902.40 | -20.62 | -26.47 | -45.22 | -47.32 | 66.84 | 60.56 | -39.21 | -52.54 | 1.03 | 0.057 | 0.5958 | -- | 1.84 | 19.16 | -13.27 | -- | -- | -- |
| Medicus Pharma Ltd | -100.00bn | -100.00bn | 25.87m | -- | -- | -- | -- | -- | -- | -- | -- | -0.0434 | -- | -- | -- | -- | -- | -361.95 | -- | -- | -- | -- | -- | -- | -- | -- | 1.13 | -- | -- | -- | -109.90 | -- | -- | -- |
| TherapeuticsMD Inc | 2.80m | 73.00k | 27.55m | 1.00 | 381.41 | 1.00 | 59.88 | 9.85 | 0.0062 | 0.0261 | 0.2419 | 2.37 | 0.0715 | -- | 0.8002 | 2,796,000.00 | 0.1867 | -42.65 | 0.2169 | -112.14 | -- | -- | 2.61 | -193.47 | -- | -5,240.00 | 0.00 | -- | 35.25 | -48.72 | 69.97 | -- | -- | -- |
| Healthy Extracts Inc | 3.59m | -1.17m | 29.19m | 2.00 | -- | 1.21 | -- | 8.13 | -0.3195 | -0.3195 | 0.9095 | 1.43 | 0.2505 | 1.42 | 140.67 | 1,794,555.00 | -8.19 | -61.21 | -9.09 | -111.60 | 52.37 | 51.30 | -32.71 | -82.01 | 0.6491 | -2.84 | 0.0421 | -- | 25.24 | 32.99 | 66.01 | -- | -- | -- |
| United-Guardian Inc | 10.06m | 1.96m | 30.74m | 24.00 | 15.68 | 2.90 | 14.89 | 3.06 | 0.4266 | 0.4266 | 2.19 | 2.30 | 0.7911 | 3.82 | 7.58 | 419,180.40 | 15.41 | 26.91 | 17.85 | 31.16 | 50.60 | 54.16 | 19.48 | 26.97 | 6.16 | -- | 0.00 | 92.34 | 11.91 | -2.18 | 25.94 | -7.35 | 30.65 | -8.64 |
| Hyperion DeFi Inc | 345.32k | -26.40m | 31.35m | 13.00 | -- | 0.3746 | -- | 90.78 | -20.32 | -20.32 | 0.0385 | 9.88 | 0.0065 | -- | 1.06 | 26,563.08 | -48.31 | -102.28 | -59.47 | -168.53 | -798.11 | 60.58 | -7,385.51 | -856.97 | -- | -- | 0.0976 | -- | 1,412.93 | -- | -82.75 | -- | -0.6271 | -- |
| Kyntra Bio Inc | 8.30m | -131.13m | 31.47m | 225.00 | -- | -- | -- | 3.79 | -32.49 | 53.34 | 2.05 | -4.21 | 0.0413 | -1.47 | 0.421 | 36,880.00 | -64.00 | -39.47 | -260.98 | -61.33 | 345.69 | 90.21 | -1,548.18 | -199.02 | 3.60 | -- | 0.5269 | -- | -36.71 | -35.07 | 52.60 | -- | -45.94 | -- |
| SCYNEXIS Inc | 2.93m | -25.30m | 34.04m | 28.00 | -- | 0.9342 | -- | 11.61 | -0.5107 | -0.5107 | 0.0593 | 0.8683 | 0.0391 | -- | 0.5776 | 104,714.30 | -33.71 | -20.51 | -43.65 | -24.97 | 33.32 | -- | -862.89 | -64.82 | -- | -- | 0.00 | -- | -97.33 | 98.68 | -131.75 | -- | -- | -- |
| BioXcel Therapeutics Inc | 752.00k | -68.21m | 36.30m | 37.00 | -- | -- | -- | 48.28 | -10.41 | -10.41 | 0.1023 | -4.45 | 0.016 | 0.9718 | 501.33 | 20,324.32 | -145.62 | -76.45 | -449.90 | -88.28 | -28.19 | -- | -9,070.61 | -14,760.23 | 1.16 | -3.25 | 5.40 | -- | 64.20 | -- | 66.71 | -- | -- | -- |
| Celularity Inc | 40.58m | -80.71m | 36.62m | 123.00 | -- | -- | -- | 0.9026 | -3.34 | -3.34 | 1.69 | -0.7121 | 0.3339 | 6.14 | 5.24 | 329,902.40 | -66.35 | -23.42 | -158.76 | -26.83 | 50.61 | -- | -198.75 | -294.70 | 0.123 | -6.57 | 2.01 | -- | 138.11 | -- | 70.51 | -- | -- | -- |
Data as of Feb 11 2026. Currency figures normalised to TherapeuticsMD Inc's reporting currency: US Dollar USD
27.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rubric Capital Management LPas of 30 Sep 2025 | 1.19m | 10.30% |
| Clearline Capital LPas of 30 Sep 2025 | 635.22k | 5.49% |
| Tejara Capital Ltd.as of 31 Dec 2025 | 350.85k | 3.03% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 328.29k | 2.84% |
| Adar1 Capital Management LLCas of 30 Sep 2025 | 209.21k | 1.81% |
| Morgan Stanley & Co. LLCas of 30 Sep 2025 | 129.60k | 1.12% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 116.13k | 1.00% |
| Geode Capital Management LLCas of 30 Sep 2025 | 109.08k | 0.94% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 63.83k | 0.55% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 35.50k | 0.31% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
